VRXA Veraxa Biotech AG

P/E --
Forward P/E --
Price/Sales 7605.82
Beta 0.192
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Veraxa Biotech is trading 11.59% down today with no identified company-specific catalyst

Veraxa Biotech is trading 11.59% down now at $1.45 after falling from its August 26 close of $1.64, with no credible company-specific announcement or filing...

πŸ”΄ Veraxa Biotech is trading 5.49% down today with no credible company-specific explanation

Veraxa Biotech is trading at $1.40, down 5.49%, with no credible company-specific announcement or filing dated August 27, 2026 explaining the decline. β€’...

πŸ”΄ Veraxa Biotech is trading 5.78% down today β€” no clear catalyst identified

Veraxa Biotech is trading 5.78% down at $1.63 on August 26, 2026, with no clear company-specific announcement or catalyst identified to explain the decline. -...

πŸ”΄ Veraxa Biotech is trading 10.26% down today amid broader biotech weakness

Veraxa Biotech is trading 10.26% down at $1.75 amid broader weakness across biotechnology shares. - The company announced positive early...

πŸ”΄ Veraxa Biotech is trading 7.69% down today amid broader biotech weakness

Veraxa Biotech is trading 7.69% down now at $1.80, amid broad weakness in biotechnology shares. - On August 24, 2026, Veraxa Biotech and Secarna...

🟒 Veraxa Biotech is trading 5.8% up today amid XBI's 2.02% gain

Veraxa Biotech is trading 5.8% up at $2.00, with the move most consistent with positive biotech-sector momentum. - The stock is outperforming its recent...

🟒 Veraxa Biotech rises 5.0% β€” Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results

With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...

πŸ”΄ Veraxa Biotech is trading 5.55% down today with no clear company-specific catalyst

Veraxa Biotech is trading 5.55% down at $1.88 after no clear company-specific catalyst emerged on August 10, 2026. - The company’s official news page shows...

🟒 Veraxa Biotech is trading 5.9% up today amid broader biotech strength

Veraxa Biotech is trading 5.9% up now at $1.97, with broader strength across biotechnology stocks appearing to be the clearest explanation. - An...

🟒 Veraxa Biotech is trading 6.1% up today amid a broader biotech sector rally

Veraxa Biotech is trading 6.1% up at $1.91 today, driven primarily by a broader biotech sector rally and risk-on market sentiment rather than a distinct new...

🟒 Veraxa Biotech is trading 5.11% up today amid broader market strength

Veraxa Biotech is trading at $1.85 (+5.11%) with no company-specific catalysts identified, suggesting the move is consistent with the broader market rally. β€’...

πŸ”΄ Veraxa Biotech is trading 5% down today amid sector-wide biotech weakness

Veraxa Biotech is trading at $1.85, down 5% today, as the stock faces downward pressure alongside the broader biotech sector and cautious market sentiment. *...

🟒 Veraxa Biotech is trading 6.06% up today on rebound buying after recent volatility

Veraxa Biotech is trading at $2.10 (+6.06%) on July 29, 2026, amid a volatile two-day rebound following a prior pullback. * The move appears consistent with...

πŸ”΄ Veraxa Biotech is trading 5.5% down today on sector weakness following its recent sharp rebound

Veraxa Biotech is trading 5.5% down at $1.90 today as it pulls back alongside a weaker biotech sector and cooling market risk appetite. β€’ The stock is giving...

🟒 Veraxa Biotech is trading 8.8% up today on broader biotech sector strength and improved risk appetite

Veraxa Biotech is trading 8.8% up at $2.19 in pre-market, extending a sharp rebound driven by broader biotech sector strength and improved risk appetite. β€’...

🟒 Veraxa Biotech is trading 16.1% up today on broader biotech sector rally

Veraxa Biotech is trading 16.1% up today at $2.02, rebounding after last week’s weakness as risk appetite returns to the biotech sector. β€’ The move appears...

🟒 Veraxa Biotech is trading 6% up today on broader risk-on sentiment

Veraxa Biotech is trading 6% up today at $1.91, bouncing back after last week’s pullback as broader market sentiment improves. β€’ The move aligns with a...

🟒 Veraxa Biotech is trading 5.6% up today on broader risk-on sentiment tailwind

Veraxa Biotech is trading at $1.90 (5.6%) up in pre-market, rebounding modestly after last week’s steady declines. β€’ The gain appears aligned with broader...

πŸ”΄ Veraxa Biotech is trading 10.2% down

Veraxa Biotech is trading at $1.84, down 10.2% from a comparison close of $2.05 during regular trading. This is a price-action follow-up, so a separate...

🟒 Veraxa Biotech is trading 6.4% up today on positive BiTAC pipeline updates and German regulatory feedback

Veraxa Biotech is trading 6.4% up today at $2.25, reflecting investor enthusiasm for recent progress on its BiTAC cancer therapy platform. β€’ The company...